Log In
BCIQ
Print this Print this
 

AT-301

  Manage Alerts
Collapse Summary General Information
Company Medigen Biotechnology Corp.
DescriptionInactivated H5N1 influenza vaccine produced in madin-darby canine kidney (MDCK) cells
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationInfluenza virus
Indication DetailsPrevent H5N1 avian influenza virus infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today